Huperzine A protects isolated rat brain mitochondria against β-amyloid peptide

Free Radical Biology and Medicine

Volumn 46, Issue 11, 2009, Pages 1454-1462

  Gao, Xin ^a   Zheng, Chun Yan ^a   Yang, Ling ^a   Tang, Xi Can ^a   Zhang, Hai Yan ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Amyloid peptide; Free radicals; Huperzine A; Mitochondria; Oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN[25-35]; CITRATE SYNTHASE; CYTOCHROME C; HUPERZINE A; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME SYNTHESIS; MALE; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL DEATH; CELL RESPIRATION; CHOLINESTERASE INHIBITORS; CYTOPROTECTION; FREE RADICALS; HUPERZIA; MALE; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; PEPTIDE FRAGMENTS; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; SESQUITERPENES;

ANIMALIA; RATTUS;

EID: 67349281227     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.02.028     Document Type: Article

References (77)

1. Blass J.P. Cerebrometabolic abnormalities in Alzheimer's disease. Neurol. Res. 25 (2003) 556-566
2. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., and Kuhl D. E., Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42 (1997) 85-94
3. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
4. Robertson C.L., Soane L., Siegel Z.T., and Fiskum G. The potential role of mitochondria in pediatric traumatic brain injury. Dev. Neurosci. 28 (2006) 432-446
5. Hauptmann S., Scherping I., Drose S., Brandt U., Schulz K.L., Jendrach M., Leuner K., Eckert A., and Muller W.E. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging (2008) Feb 21 [Epub ahead of print]
6. Liang W.S., Reiman E.M., Valla J., Dunckley T., Beach T.G., Grover A., Niedzielko T.L., Schneider L.E., Mastroeni D., Caselli R., Kukull W., Morris J.C., Hulette C.M., Schmechel D., Rogers J., and Stephan D.A. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. USA 105 (2008) 4441-4446
7. Blass J.P. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?. J. Neurosci. Res. 66 (2001) 851-856
8. Anandatheerthavarada H.K., and Devi L. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 13 (2007) 626-638
9. Selkoe D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8 (1998) 447-453
10. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
11. LaFerla F.M., Green K.N., and Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8 (2007) 499-509
12. Li M., Chen L., Lee D.H., Yu L.C., and Zhang Y. The role of intracellular amyloid beta in Alzheimer's disease. Prog. Neurobiol. 83 (2007) 131-139
13. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., and Reddy P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15 (2006) 1437-1449
14. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., and Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
15. Wang X., Su B., Perry G., Smith M.A., and Zhu X. Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease. Free Radic. Biol. Med. 43 (2007) 1569-1573
16. Reddy P.H., and Beal M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14 (2008) 45-53
17. Wang R., Yan H., and Tang X.C. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin. 27 (2006) 1-26
18. Li J., Wu H.M., Zhou R.L., Liu G.J., and Dong B.R. Huperzine A for Alzheimer's disease. Cochrane Database Syst. Rev. CD005592 (2008)
19. Zhang H.Y., and Tang X.C. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease. Trends Pharmacol. Sci. 27 (2006) 619-625
20. Zhang H.Y., Yan H., and Tang X.C. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase. Cell. Mol. Neurobiol. 28 (2008) 173-183
21. Wang R., Zhang H.Y., and Tang X.C. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat. Eur. J. Pharmacol. 421 (2001) 149-156
22. Liang Y.Q., Huang X.T., and Tang X.C. Huperzine A reverses cholinergic and monoaminergic dysfunction induced by bilateral nucleus basalis magnocellularis injection of beta-amyloid peptide (1-40) in rats. Cell. Mol. Neurobiol. 28 (2008) 87-101
23. Xiao X.Q., Zhang H.Y., and Tang X.C. Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J. Neurosci. Res. 67 (2002) 30-36
24. Gao X., and Tang X.C. Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J. Neurosci. Res. 83 (2006) 1048-1057
25. Lai J.C., and Clark J.B. Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol. 55 (1979) 51-60
26. Aleardi A.M., Benard G., Augereau O., Malgat M., Talbot J.C., Mazat J.P., Letellier T., Dachary-Prigent J., Solaini G.C., and Rossignol R. Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J. Bioenerg. Biomembr. 37 (2005) 207-225
27. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
28. Berman S.B., Watkins S.C., and Hastings T.G. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria. Exp. Neurol. 164 (2000) 415-425
29. Hillered L., and Chan P.H. Effects of arachidonic acid on respiratory activities in isolated brain mitochondria. J. Neurosci. Res. 19 (1988) 94-100
30. Rosenthal R.E., Hamud F., Fiskum G., Varghese P.J., and Sharpe S. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 7 (1987) 752-758
31. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73 (1999) 1127-1137
32. Drew B., and Leeuwenburgh C. Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R1259-1267
33. Estornell E., Fato R., Pallotti F., and Lenaz G. Assay conditions for the mitochondrial NADH:coenzyme Q oxidoreductase. FEBS Lett. 332 (1993) 127-131
34. King T.E. Preparations of succinate-cytochrome c reductase and the cytochrome b-c1 particle, and reconstitution of succinate-cytochrome c reductase. Methods Enzymol. 10 (1967) 216-225
35. Wharton D.C., and Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10 (1967) 245-250
36. Trounce I.A., Kim Y.L., Jun A.S., and Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264 (1996) 484-509
37. Lai J.C., and Cooper A.J. Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J. Neurochem. 47 (1986) 1376-1386
38. Elnageh K.M., and Gaitonde M.K. Effect of a deficiency of thiamine on brain pyruvate dehydrogenase: enzyme assay by three different methods. J. Neurochem. 51 (1988) 1482-1489
39. Pensalfini A., Cecchi C., Zampagni M., Becatti M., Favilli F., Paoli P., Catarzi S., Bagnoli S., Nacmias B., Sorbi S., and Liguri G. Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress. Free Radic. Biol. Med. 44 (2008) 1624-1636
40. Ju T.C., Chen S.D., Liu C.C., and Yang D.I. Protective effects of S-nitrosoglutathione against amyloid β-peptide neurotoxicity. Free Radic. Biol. Med. 38 (2005) 938-949
41. Zeng H., Chen Q., and Zhao B. Genistein ameliorates β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic. Biol. Med. 36 (2004) 180-188
42. 2+-induced oxidative stress in brain mitochondria treated with the respiratory chain inhibitor rotenone. FEBS Lett. 543 (2003) 179-183
43. Friberg H., Wieloch T., and Castilho R.F. Mitochondrial oxidative stress after global brain ischemia in rats. Neurosci. Lett. 334 (2002) 111-114
44. Liu X.H., Aksan A., Menze M.A., Hand S.C., and Toner M. Trehalose loading through the mitochondrial permeability transition pore enhances desiccation tolerance in rat liver mitochondria. Biochim. Biophys. Acta 1717 (2005) 21-26
45. Clementi M.E., Marini S., Coletta M., Orsini F., Giardina B., and Misiti F. Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett. 579 (2005) 2913-2918
46. Bernardi P., Broekemeier K.M., and Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore: a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr. 26 (1994) 509-517
47. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
48. Zheng C.Y., Zhang H.Y., and Tang X.C. Huperzine A attenuates mitochondrial dysfunction after middle cerebral occlusion in rats. J. Neurosci. Res. 86 (2008) 2432-2440
49. Casley C.S., Canevari L., Land J.M., Clark J.B., and Sharpe M.A. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80 (2002) 91-100
50. Thorburn D.R. Diverse powerhouses. Nat. Genet. 36 (2004) 13-14
51. Ogawa S., and Lee T.M. The relation between the internal phosphorylation potential and the proton motive force in mitochondria during ATP synthesis and hydrolysis. J. Biol. Chem. 259 (1984) 10004-10011
52. Brand M.D., Chien L.F., Ainscow E.K., Rolfe D.F., and Porter R.K. The causes and functions of mitochondrial proton leak. Biochim. Biophys. Acta 1187 (1994) 132-139
53. Lesnefsky E.J., and Hoppel C.L. Oxidative phosphorylation and aging. Ageing Res. Rev. 5 (2006) 402-433
54. Masini A., Ceccarelli-Stanzani D., and Muscatello U. The effect of oligomycin on rat liver mitochondria respiring in state 4. FEBS Lett. 160 (1983) 137-140
55. Robertson C.L., Puskar A., Hoffman G.E., Murphy A.Z., Saraswati M., and Fiskum G. Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp. Neurol. 197 (2006) 235-243
56. +/ATP ratio during ATP hydrolysis by mitochondria: modification of the chemiosmotic theory. Proc. Natl. Acad. Sci. USA 74 (1977) 1955-1959
57. Zoratti M., Pietrobon D., and Azzone G.F. Studies on the relationship between ATP synthesis and transport and the proton electrochemical gradient in rat liver mitochondria. Biochim. Biophys. Acta 723 (1983) 59-70
58. Yoshikawa S., Muramoto K., Shinzawa-Itoh K., Aoyama H., Tsukihara T., Shimokata K., Katayama Y., and Shimada H. Proton pumping mechanism of bovine heart cytochrome c oxidase. Biochim. Biophys. Acta 1757 (2006) 1110-1116
59. Tretter L., and Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20 (2000) 8972-8979
60. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84
61. Rattan S.I. Theories of biological aging: genes, proteins, and free radicals. Free Radic. Res. 40 (2006) 1230-1238
62. Marlatt M., Lee H.G., Perry G., Smith M.A., and Zhu X. Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. Acta Neurobiol. Exp. (Warsaw) 64 (2004) 81-87
63. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 (2004) S18-25 Suppl.
64. Kaminsky Y.G., and Kosenko E.A. Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo. Free Radic. Res. 42 (2008) 564-573
65. Takuma K., Yao J., Huang J., Xu H., Chen X., Luddy J., Trillat A.C., Stern D.M., Arancio O., and Yan S.S. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J. 19 (2005) 597-598
66. Choksi K.B., Boylston W.H., Rabek J.P., Widger W.R., and Papaconstantinou J. Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim. Biophys. Acta 1688 (2004) 95-101
67. Xiao X.Q., Yang J.W., and Tang X.C. Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury. Neurosci. Lett. 275 (1999) 73-76
68. Xiao X.Q., Wang R., and Tang X.C. Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J. Neurosci. Res. 61 (2000) 564-569
69. Zhou J., Fu Y., and Tang X.C. Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation. Neurosci. Lett. 306 (2001) 53-56
70. Norenberg M.D., and Rao K.V. The mitochondrial permeability transition in neurologic disease. Neurochem. Int. 50 (2007) 983-997
71. Rodrigues C.M., Sola S., Brito M.A., Brondino C.D., Brites D., and Moura J.J. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem. Biophys. Res. Commun. 281 (2001) 468-474
72. Kim H.S., Lee J.H., Lee J.P., Kim E.M., Chang K.A., Park C.H., Jeong S.J., Wittendorp M.C., Seo J.H., Choi S.H., and Suh Y.H. Amyloid beta peptide induces cytochrome C release from isolated mitochondria. Neuroreport 13 (2002) 1989-1993
73. Moreira P.I., Santos M.S., Moreno A., Rego A.C., and Oliveira C. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J. Neurosci. Res. 69 (2002) 257-267
74. Dorner A., and Schultheiss H.P. Adenine nucleotide translocase in the focus of cardiovascular diseases. Trends Cardiovasc. Med. 17 (2007) 284-290
75. White R.J., and Reynolds I.J. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J. Neurosci. 16 (1996) 5688-5697
76. Stavrovskaya I.G., and Kristal B.S. The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?. Free Radic. Biol. Med. 38 (2005) 687-697
77. Wang R., and Tang X.C. Neuroprotective effects of huperzine A: a natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 14 (2005) 71-82